APP and Alzheimer disease: Disruptions to many biochemical pathways, such as amyloid precursor protein metabolism, tau protein phosphorylation, oxidative stress, mitochondrial function, inflammation, lipid metabolism, and neurotransmitter pathways, occur in AD patients [122].